SDAI 5TI

SGD 0.08 +0.00% +0.00 Updated 19 Nov 2026, 16:30 SGT

Company profile

The business, the people and the ownership behind SDAI.

Business overview

About the company

SDAI is an investment holding group that has entered the biotechnology industry. Its biotechnology activities include its subsidiary Beijing Blue Code Biotechnology, alongside the group’s other investment interests.

Annual Report 2025 ↗ Reviewed 2026-10-23 · Source dated 2026-04-14. PDF p. 4

Listed security

Company & listing

Full Company Name
SDAI LIMITED
Trading Currency
SGD
Website
www.sdai.com.sg
Listing
Listed on 22 July 2011 on Catalist
ISIN Code
SG2D45972171

Board & management

Leadership

Hao Dongting

Executive Chairperson

Board of Directors

Yap Koon Loong

Executive Director

Board of Directors

James Beeland Rogers, Jr.

Non-Executive and Non-Independent Director

Board of Directors

Lam Kwong Fai

Lead Independent Director

Board of Directors

Cheung Wai Man, Raymond

Independent Director

Board of Directors

Tan Meng Shern

Independent Director

Board of Directors

Liu Ting

Chief Executive Officer

Key Management

Roles listed in ANNUAL REPORT 2025; current appointments are not independently verified.

Holdings

Ownership

OOWAY Group Ltd.(1)

Direct interest 90,000,000 shares (21.2%); no deemed interest

Substantial shareholders

Lim Wee Li

Direct interest 66,148,657 shares (15.6%); no deemed interest

Substantial shareholders

Chee Tuck Hong

Direct interest 23,859,060 shares (5.6%); no deemed interest

Substantial shareholders

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-03-16 · PDF p. 139

Registered holderInterestShares / unitsSource
OOWAY GROUP LTD.Rank 1; 90,000,000 shares; 21.19%PDF p. 1392026-03-16
LIM WEE LIRank 2; 66,148,657 shares; 15.58%PDF p. 1392026-03-16
CHEE TUCK HONGRank 3; 23,859,060 shares; 5.62%PDF p. 1392026-03-16
CITIBANK NOMINEES SINGAPORE PTE LTDRank 4; 14,595,260 shares; 3.44% (nominee)PDF p. 1392026-03-16
DBS NOMINEES (PRIVATE) LIMITEDRank 5; 13,300,900 shares; 3.13% (nominee)PDF p. 1392026-03-16
RAFFLES NOMINEES (PTE.) LIMITEDRank 6; 12,412,000 shares; 2.92% (nominee)PDF p. 1392026-03-16
OCBC SECURITIES PRIVATE LIMITEDRank 7; 9,451,200 shares; 2.23%PDF p. 1392026-03-16
HSBC (SINGAPORE) NOMINEES PTE LTDRank 8; 7,147,200 shares; 1.68% (nominee)PDF p. 1392026-03-16
LIN SONGXIANRank 9; 6,740,700 shares; 1.59%PDF p. 1392026-03-16
CHIANG SIEW KAYRank 10; 5,521,000 shares; 1.30%PDF p. 1392026-03-16
IFAST FINANCIAL PTE. LTD.Rank 11; 5,167,700 shares; 1.22%PDF p. 1392026-03-16
MAYBANK SECURITIES PTE. LTD.Rank 12; 4,976,600 shares; 1.17%PDF p. 1392026-03-16
ONG SOON LIONG @ONG SOON CHONGRank 13; 4,900,000 shares; 1.15%PDF p. 1392026-03-16
PHILLIP SECURITIES PTE LTDRank 14; 4,875,800 shares; 1.15%PDF p. 1392026-03-16
UOB KAY HIAN PRIVATE LIMITEDRank 15; 4,772,736 shares; 1.12%PDF p. 1392026-03-16
WONG HONG ENGRank 16; 4,603,308 shares; 1.08%PDF p. 1392026-03-16
CHEE TAI CHIEWRank 17; 4,508,200 shares; 1.06%PDF p. 1392026-03-16
POON POH MUI OR NG TZE KIONGRank 18; 4,300,000 shares; 1.01%PDF p. 1392026-03-16
YANG XIANZHENGRank 19; 3,859,060 shares; 0.91%PDF p. 1392026-03-16
PAMELA RACHEL KWAN KA FOONGRank 20; 3,659,060 shares; 0.86%PDF p. 1392026-03-16

Group structure

Main operating subsidiaries

CompanyMarketOwnership interest
KHL (Hong Kong) LimitedHeld by the Company; Group proportion of equity interests, 2025 (comparative 2024 100)PDF p. 105 Country/place of business: Hong Kong; Group equity interest 2025: 100%; 2024: 100%; NCI 2025: -, 2024: -; held by the Company; Investment holding
SDAI Healthcare Pte. Ltd.Held by the Company; Group proportion of equity interests, 2025 (comparative 2024 100)PDF p. 105 Country/place of business: Singapore; Group equity interest 2025: 100%; 2024: 100%; NCI 2025: -, 2024: -; held by the Company; Trading in specialist medical equipment and related supplies
Hainan Blue Code Biotechnology Co. Ltd.Held by the Company; Group proportion of equity interests, 2025 (comparative 2024 100)PDF p. 105 Country/place of business: China; Group equity interest 2025: 100%; 2024: 100%; NCI 2025: -, 2024: -; held by the Company; Technical consulting and development services, information consulting services, natural science research and development, general sales and retail; and e-commerce
Kitchen Culture (Hong Kong) LimitedHeld by KHL; Group proportion of equity interests, 2025 (comparative 2024 70)PDF p. 105 Country/place of business: Hong Kong; Group equity interest 2025: 70%; 2024: 70%; NCI 2025: 30%, 2024: 30%; held by KHL; Sales and distribution of kitchen system, kitchen appliances, wardrobe system, household furniture and appliances
Kitchen Culture (China) LimitedHeld by KHL; Group proportion of equity interests, 2025 (comparative 2024 100)PDF p. 105 Country/place of business: Hong Kong; Group equity interest 2025: 100%; 2024: 100%; NCI 2025: -, 2024: -; held by KHL; Dormant
Blue Code Hainan (Healthcare) Co. Ltd.Held by HBCT; Group proportion of equity interests, 2025 (2024 shown as -)PDF p. 106 Country/place of business: China; Group equity interest 2025: 100%; 2024: -; NCI 2025: -, 2024: -; held by HBCT; Dormant

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
Liu Ting Chief Executive Officer PDF p. 10
Ng Kheng Jen Acting Chief Financial Officer PDF p. 10

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
Issued and fully paid capital S$59,317,003.33 Company · As at 2026-03-16 PDF p. 138
Class of shares Ordinary shares Company · As at 2026-03-16 PDF p. 138
Total number of shares in issue 424,665,283 shares Company · As at 2026-03-16 PDF p. 138
Voting rights 1 vote per share Company · As at 2026-03-16 PDF p. 138

Treasury shares

ItemValuePeriod / scopeSource
Number of treasury shares Nil Company · As at 2026-03-16 PDF p. 138
Number of subsidiary holdings held Nil Company · As at 2026-03-16 PDF p. 138
Percentage of the aggregate number of treasury shares and subsidiary holdings held Nil Company · As at 2026-03-16 PDF p. 138

Free float

ItemValuePeriod / scopeSource
Shareholdings held in the hands of public 57.61% Company · As at 2026-03-16 PDF p. 138

Shareholding distribution

ItemValuePeriod / scopeSource
TOTAL 682 holders Total shareholders · As at 2026-03-16 PDF p. 138
1 - 99 4 holders; 0.59% of holders; 229 shares; 0.00% of shares Size band 1 - 99 · As at 2026-03-16 PDF p. 138
100 - 1,000 16 holders; 2.34% of holders; 9,765 shares; 0.00% of shares Size band 100 - 1,000 · As at 2026-03-16 PDF p. 138
1,001 - 10,000 81 holders; 11.88% of holders; 571,600 shares; 0.13% of shares Size band 1,001 - 10,000 · As at 2026-03-16 PDF p. 138
10,001 - 1,000,000 531 holders; 77.86% of holders; 78,043,412 shares; 18.38% of shares Size band 10,001 - 1,000,000 · As at 2026-03-16 PDF p. 138
1,000,001 AND ABOVE 50 holders; 7.33% of holders; 346,040,277 shares; 81.49% of shares Size band 1,000,001 and above · As at 2026-03-16 PDF p. 138

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Interested Person Transaction The Group does not have any interested person transactions (excluding less than S$100,000) in FY2025 that is disclosable under Rule 920(1)(a)(ii) of the Catalist Rules. Group, FY2025 PDF p. 62
Mdm Hao Dongting the value of the transaction (being the entry into 2024 Loan) is zero Company, FY2025; interested person Mdm Hao Dongting; 2024 Loan, interest-free PDF p. 62
Mdm Hao Dongting the value of the transaction (being the entry into 2025 Loan) is zero Subsidiary Hainan Blue Code Biotechnology Co., Ltd, entered 7 March 2025; interested person Mdm Hao Dongting; interest-free working capital loan PDF p. 62
Salaries, bonuses and short-term benefits 584,824 $ The Group, 31 December 2025 (comparative 2024: 661,261) PDF p. 123
Executive Chairman and Chief Executive Officer of the Company 495,750 $ The Group, 31 December 2025 (comparative 2024: 411,219) PDF p. 123

Director remuneration

ItemValuePeriod / scopeSource
Mdm Hao Dongting 192,000 S$ FY2025, individual director/CEO remuneration PDF p. 51
Mr Yap Koon Loong(2) 216,000 S$ FY2025, individual director/CEO remuneration PDF p. 51
Mr Lam Kwong Fai(1) 70,000 S$ FY2025, individual director/CEO remuneration PDF p. 51
Mr Tan Meng Shern(1) 60,000 S$ FY2025, individual director/CEO remuneration PDF p. 51

Employees

ItemValuePeriod / scopeSource
total number of employees 11 employees Group, as at 31 December 2025 (31 December 2024: 7) · As at 2025-12-31 PDF p. 25

Subsequent events

ItemValuePeriod / scopeSource
31. Subsequent events (a) On 15 January 2026, a joint venture company, QCM Holdings Pte. Ltd. (“QCMH”), was established in Singapore. The Company holds a 55% stake, while Hubei Qiai owns 45% in QCMH. Group PDF p. 137
31. Subsequent events (b) On 13 March 2026, the Company entered into six separate redeemable loan agreements Company PDF p. 137
31. Subsequent events (d) On 13 March 2026, the Company entered into a supplemental agreement with a director to grant the extension of the $4,000,000 loan (Note 17(ii)) for an additional 18 months from its maturity date, 30 June 2026 Company PDF p. 137

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Source: ANNUAL REPORT 2025 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
25 Mar 2011
Telephone
65 6818 6201
Registered Office
Level 39 Marina Bay Financial Centre
Tower 2
10 Marina Boulevard
Singapore 018983
Secretary
Tan Swee Gek
Ong Beng Hong
Registrar / Transfer Agent
ASCENTIUM CORPORATE SERVICES PTE. LTD.
Registrar Address
36 Robinson Road, #20-01 City House, Singapore 068877
Auditors
FOO KON TAN LLP
Other Stock Exchange Listings
*SINGAPORE EXCHANGE (CATALIST)
Country
SINGAPORE
Security Type
stocks